Aterian, Inc. (ATER)
| Market Cap | 14.64M +86.1% |
| Revenue (ttm) | 68.85M +35.0% |
| Net Income | -16.85M |
| EPS | -1.95 |
| Shares Out | 16.34M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,049,303 |
| Open | 0.7200 |
| Previous Close | 0.7100 |
| Day's Range | 0.7000 - 0.9000 |
| 52-Week Range | 0.3541 - 1.8700 |
| Beta | 0.84 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |
About ATER
Aterian, Inc., together with its subsidiaries, operates as a consumer products company in North America, Chile, Colombia, Argentina, and internationally. The company offers home and kitchen appliances, kitchenware, air quality appliances, health and beauty products, and essential oils under the Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct brand names. It primarily serves individual online consumers through online retail channels, such as Amazon, Walmart, and Target; Amazon US, owned and operated w... [Read more]
Financial Performance
In 2025, Aterian's revenue was $68.98 million, a decrease of -30.36% compared to the previous year's $99.05 million. Losses were -$18.98 million, 60.0% more than in 2024.
Financial StatementsNews
Aterian Quarterly report: Q2 2026
Aterian has published its Q2 2026 quarterly earnings report on August 14, 2026.
Aterian files to sell 6.74M shares of common stock for holders
16:59 EDT Aterian (ATER) files to sell 6.74M shares of common stock for holders
Aterian Registration statement: Registration filing
Aterian filed a registration statement on July 20, 2026, providing details about a securities offering with the SEC.
Aterian Issues Urgent Call to Action: Only 285,000 Votes or 2.7% Separates Stockholders From Securing Value
SUMMIT, N.J., July 13, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (NASDAQ: ATER) ("Aterian" or the "Company") today issued an urgent message to its stockholders announcing that it has adjourned its origin...
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on July 13, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Transcript: EGM 2026
The meeting focused on an asset sale proposal, which did not receive enough votes for approval. The board adjourned the meeting to allow more time for shareholders to vote, aiming for a decision by July 17th and highlighting potential returns and new business opportunities.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on July 10, 2026, providing details for shareholder voting and corporate governance matters.
Both Leading Independent Proxy Advisors Recommend Aterian Stockholders Vote for the Asset Sale
SUMMIT, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (NASDAQ: ATER) (“Aterian” or the “Company”) today announced that both leading independent proxy advisory firms Glass, Lewis & Co. (“Glass ...
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on July 8, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Urges Stockholders to Vote “FOR” All Proposals at the Upcoming Special Meeting of Stockholders on July 10, 2026
Board-Approved Transactions Expected to Return $0.85–$1.14 Per Share to Stockholders Board-Approved Transactions Expected to Return $0.85–$1.14 Per Share to Stockholders
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on July 6, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on July 2, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on June 29, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on June 26, 2026, providing details for shareholder voting and corporate governance matters.
Aterian, Inc. Announces Mailing of Proxy Materials for Special Meeting of Stockholders
SUMMIT, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced that it has mailed proxy materials previously fi...
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on June 18, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on June 11, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on June 9, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on June 8, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on June 1, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Quarterly report: Q1 2026
Aterian has published its Q1 2026 quarterly earnings report on May 15, 2026.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on May 15, 2026, providing details for shareholder voting and corporate governance matters.
Aterian Proxy statement: Proxy filing
Aterian filed a proxy statement on April 29, 2026, providing details for shareholder voting and corporate governance matters.
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
SUMMIT, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a consumer products company, today announced separate transactions related to its previously...
Aterian provides update on strategic alternative process
Aterian (ATER) provided the following update on its previously announced strategic alternative process. “Our Strategic Alternative Process is progressing well since our first announcement in December ...